Results 131 to 140 of about 109,733 (324)
The Effectiveness of Incentive Spirometry With Physical Therapy for High-Risk Patients After Coronary Artery Bypass Surgery [PDF]
Jean Crowe, Christine A. Bradley
openalex +1 more source
Clustering Longitudinal Data: A Review of Methods and Software Packages
Summary Clustering of longitudinal data is becoming increasingly popular in many fields such as social sciences, business, environmental science, medicine and healthcare. However, it is often challenging due to the complex nature of the data, such as dependencies between observations collected over time, missingness, sparsity and non‐linearity, making ...
Zihang Lu
wiley +1 more source
Aim Combining preoperative spirometry with the Assess Respiratory Risk in Surgical Patients in Catalunia (ARISCAT) risk scale can reduce post-operative complications and improve patient survival.
Yolanda Mares-Gutiérrez+5 more
doaj
A Study of the Usefluness of Forced Expiratory Spirometry as a Preoperative Laboratory Screeing in the Elderly Patient [PDF]
Byung Sung Kang+4 more
openalex +1 more source
ABSTRACT Aim To explore Registered Nurses' experiences of continuity of care for patients with chronic obstructive pulmonary disease in primary care. Design An inductive, descriptive qualitative study. Methods Data were collected through semi‐structured interviews with 11 purposively sampled Registered Nurses of varying levels of experience from eight ...
Sara Roos+3 more
wiley +1 more source
The value of spirometry for primary care: Asthma and COPD [PDF]
Tjard Schermer+5 more
openalex +1 more source
This systematic review and meta‐analysis evaluates the impact of SGLT‐2 inhibitors on COPD exacerbations in patients with Type 2 diabetes mellitus (T2DM). Our findings demonstrate that SGLT‐2 inhibitors significantly reduce the frequency of COPD exacerbations by 35% compared to other antidiabetic agents, offering dual benefits in glycemic control and ...
Muhammed Shabil+14 more
wiley +1 more source
Spirometry for patients in hospital and one month after admission with an acute exacerbation of COPD
Harry Rea1, Timothy Kenealy1, Jacqui Adair1, Elizabeth Robinson2, Nicolette Sheridan31Section of Integrated Care, South Auckland Clinical School, University of Auckland, 2Biostatistics and Epidemiology, School of Population Health, University of Auckland,
Rea H+4 more
doaj
Lemborexant 10 mg, a dual orexin‐receptor antagonist (DORA), did not elicit respiratory depressant effects, as measured by peripheral oxygen saturation (SpO2) or apnea–hypopnea index (AHI), in subjects with moderate‐to‐severe chronic obstructive pulmonary disease (COPD).
Jocelyn Y. Cheng+3 more
wiley +1 more source